Alli Sales Slender On Lower Retailer Demand, Flatten GSK Consumer Sales

Significantly lower sales of GlaxoSmithKline's alli OTC weight-loss drug combined with struggles in the nicotine replacement therapy category weighed down the consumer health care division's performance in the firm's latest quarter